Should You Invest in Ozempic Maker Novo Nordisk in 2026? [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
The pill could reaccelerate Novo Nordisk's top-line growth, potentially igniting a strong stock comeback from its depressed valuation. 10 stocks we like better than Novo Nordisk › Is there a more popular health trend right now than GLP-1 agonist obesity drugs such as Ozempic? Probably not. Ironically, though, investing in Ozempic , or rather in its manufacturer, Novo Nordisk (NYSE: NVO) , hasn't gone very well this year. Shares have fallen by 40% in 2025. Competition from Eli Lilly 's similar drug, Zepbound, and from telehealth companies selling compounded versions of Ozempic pressured Novo Nordisk's business to the point that the company fired its CEO earlier this year. Investing in a cold stock like Novo Nordisk can feel a bit scary, but things could be starting to heat up again for the pharmaceutical giant. Novo Nordisk shares jumped on Tuesday following news that the Food and Drug Administration (FDA) had formally approved its application to sell a pill form of Wegovy i
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access [Yahoo! Finance]Yahoo! Finance
- Health care will get more expensive for some in 2026 — and cheaper for others [MSNBC.com]MSNBC.com
- Novo Nordisk (CPSE:NOVO B) Is Up 9.0% After FDA Clears First Oral Wegovy Pill [Yahoo! Finance]Yahoo! Finance
- U.S. regulators approve Wegovy pill for weight loss [Los Angeles Times (CA)]Los Angeles Times
- Novo, Lilly race to cement lead in India's obesity drug market, Reuters says [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website